Pro­to­cols: BU’s Out­ter­son helms $350M an­tibi­otics project; Adap­ti­m­mune lands on EMA’s in­side track

Kevin Out­ter­son of Boston Uni­ver­si­ty’s School of Law has been tapped to run the new CARB-X pro­gram, a $350 mil­lion, pub­lic/pri­vate project that will bring to­geth­er part­ners on both sides of the At­lantic to spur the pre­clin­i­cal de­vel­op­ment of new an­tibi­otics. HHS is pro­vid­ing $30 mil­lion to help fund the ef­fort in its first year. Grow­ing re­sis­tance to an­tibi­otics has steadi­ly raised the threat posed by new su­per­bugs now in cir­cu­la­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.